Preoperative Dual Immunotherapy Shows Promise in High-Risk Early HER2-Negative Breast Cancer
WASHINGTON — A combination of two immunotherapy drugs produced substantially higher rates of tumor eradication when added to chemotherapy before ...
Tag: high-risk early-stage breast cancer
Liquid Biopsy Offers Breakthrough in Predicting Breast Cancer Immunotherapy Response
Immunotherapy has revolutionized the treatment landscape for many cancers, including high-risk, early-stage breast cancers. Despite its transformative potential, immunotherapy has ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!